ArticleNature communications2023

Neural deficits in a mouse model of PACS1 syndrome are corrected with PACS1- or HDAC6-targeting therapy.

Sabrina Villar-Pazos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.